Cannabis Report
Home > Boards > US Listed > Biotechs >

LCI - Lannett Company, Inc. (LCI)

Add LCI Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 9/27/2017 1:48:09 PM - Followers: 7 - Board type: Free - Posts Today: 0


About Lannett Company Inc

nyse openning bell

Lannett Company, Inc. manufactures and distributes high quality affordable generic medications that are the therapeutic equivalent of the brand-name  pharmaceuticals. Our portfolio consists of numerous products across a wide range of therapeutic areas. We believe that our ability to select viable products for development, efficiently develop such products, including obtaining any applicable regulatory approvals, vertically integrate ourselves into certain specialty markets and achieve economies in production are all critical for our success in the generic pharmaceutical industry in which we operate.

Employing our manufacturing expertise, low overhead expenses and efficient product development, manufacturing and marketing capabilities will help us remain competitive in the general pharmaceutical market. We continue to dedicate significant capital toward developing new products as we believe our success is linked to our ability to continually introduce new generic products into the marketplace.

Having cultivated strong and dependable customer relationships by maintaining adequate inventory levels and demonstrating a responsive order filling system, we take pride in our ability to satisfy our customers needs. In doing so, a majority of our orders are filled and shipped either on the day of, or the day following, the date that we receive the order.

Our manufacturing facility consists of 31,000 square feet on an approximately 3.5-acre parcel of land that we own. We also own a 63,000 square foot building on approximately 3.0 acres located within one mile of our manufacturing facility that houses packaging, R&D and certain administrative functions. In addition, we recently purchased a third building located several miles from our manufacturing facility, consisting of 66,000 square feet on approximately 7.3 acres. This building will be used as our main distribution facility as well as housing key administrative functional areas supporting the organization.

Lannett Company News

Contacts: Robert Jaffe 
PondelWilkinson Inc. 
(310) 279-5980 

Philadelphia, PA - June 24, 2011 - Lannett Company, Inc. (NYSE AMEX: LCI) today announced that 
the U.S. Food and Drug Administration (FDA) has approved the company's 505(b)(2) New Drug 
Application (NDA) for Morphine Sulfate Oral Solution on June 23, 2011.  Sales of Morphine Sulfate Oral 
Solution for the last 12 months at Average Wholesale prices (AWP) were approximately $31.7 million, 
according to Wolters Kluwer.  The company expects to commence shipping the product shortly. 
"This is first drug approval Lannett has received using a 505(b)(2) application," said Arthur P. Bedrosian, 
president and chief executive officer of Lannett.  "We applaud the dedicated efforts or our team and thank 
our shareholders for their patience and faith in our ability to re-launch this important medication." 
Bedrosian went on to say that the company is expecting to receive approvals for a number of Abbreviated 
New Drug Applications (ANDAs) currently pending at the FDA, and looks forward to working with the 
agency, both locally and in Maryland, on other 505(b)(2) NDA filings. 
About Lannett Company, Inc.: 
Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic 
pharmaceutical products for a wide range of indications.  For more information, visit the company's 
website at

Cannabis Report
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
News News Alert: Initial Statement of Beneficial Ownership (3) 07/16/2018 04:18:51 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#70   nice move on oxy approval snupoled 09/27/17 01:48:09 PM
#69 Avispa 08/17/17 08:55:37 AM
#68   Bullish pullback Flag setup. Mactheriverrat 04/14/17 02:41:07 PM
#67   LCI 2YR CHART FUGLEEEE [SMART MONEY] 03/14/17 08:05:22 PM
#66   What a major POS. binks 09/29/16 01:58:45 PM
#63   I'm thinking Insiders have to use a dividend JRS 03/17/16 02:10:47 PM
#62   I've got LCI on Watch. JRS 03/17/16 02:09:11 PM
#61   Earnings Behemoth; EPS 2015: $3.13 JRS 03/17/16 02:08:04 PM
#60   Traded sideways for about 10 years in the JRS 03/17/16 02:05:45 PM
#59   Insiders Recently Bought the Hell out of It. JRS 03/17/16 02:03:40 PM
#58   Trading Close to 52wk Low: $18.02 JRS 03/17/16 02:02:56 PM
#57   Looks like an FDA dud, I'm out. RocketInFlight 12/18/14 02:31:37 PM
#56   $LCI moving now RocketInFlight 12/18/14 01:48:12 PM
#55   In $LCI @ $44.09 RocketInFlight 12/18/14 01:39:16 PM
#54   Just received FDA approval Let's see how it RocketInFlight 12/18/14 01:23:00 PM
#53   $LCI DD Notes ~ stocktrademan 11/01/14 10:41:38 AM
#52   Roth Capital Maintains Buy On Lannett Following Earnings maytepper 08/25/14 03:45:09 PM
#51   $LCI Lannett: Oxycodone Hydrochloride Approval Incremental Plus, Says maytepper 08/04/14 04:35:58 PM
#50   chart is looking more promising now! Mithrandir67 04/30/14 07:52:19 AM
#49   falling knife now and ney burner - hands Mithrandir67 04/04/14 12:30:54 PM
#48   need to correct myself - it's dropping 10% Mithrandir67 03/24/14 11:31:28 AM
#47   why is it dropping now 5% every day? :-( Mithrandir67 02/25/14 11:22:06 AM
#46   Four insider purchases over the past month, from Steponit 01/06/14 11:56:59 AM
#45   tooshey! ;-) starbuxsux 12/04/13 11:13:26 AM
#44   May be no. free_bee 12/04/13 11:11:26 AM
#43   awesome!! congrats! buccaneer1961 12/04/13 11:09:14 AM
#42   You're a little late... after my alert following starbuxsux 12/04/13 11:05:29 AM
#41   This company has been FLYING high on Lannett free_bee 12/04/13 10:42:23 AM
#40   $LCI - This chart says it has a starbuxsux 10/14/13 04:39:42 PM
#39 The interview free_bee 09/11/13 09:54:27 PM
#38   For the fiscal 2013 fourth quarter, net sales free_bee 09/11/13 01:31:30 PM
#37   Earnings improving and multiple big potential revenue catylists Bull Bet 05/29/12 05:00:27 PM
#36   ~ $LCI ~ Earnings posted, pending or coming Penny Roger$ 02/07/12 01:02:01 AM
#35   VERY GOOD DD! Can you list those mlkrborn 01/30/12 01:47:09 PM
#34   Lannett receives FDA approval for hydrochlorothiazide capsules (LCI) mlkrborn 01/30/12 01:45:45 PM
#33   12 Drugs awaiting FDA approval + 42 Drugs Stockhero1 11/28/11 08:25:00 AM
#32   LCI GETTING CONFIRMED WITH DIFFERENT MGs.. $4.00 mlkrborn 09/27/11 10:21:59 AM
#31   $LCI - Lannett Launches Morphine Sulfate Oral Solution: HIM 08/12/11 07:03:36 AM
#30   I hold a position in this company. rikmand 08/07/11 11:42:57 AM
#29   8:11AM Lannett receives FDA approval for Phentermine resin surf1944 07/29/11 09:11:51 AM
#28   Do you think that he is an insider.EOM HIM 07/21/11 12:01:38 AM
#27   I was looking into the Broadfin 13g yesterday healey 07/20/11 09:34:15 AM
#26   $LCI : Broadfin Capital more than Doubles Stake HIM 07/19/11 11:28:35 PM
#25   LCI $4.60... FDA approved.Lannett receives FDA approval mlkrborn 07/18/11 04:57:39 PM
#24   Lannett Receives FDA Approval for Diethylproprion HCl Tablets, invest2win 07/18/11 02:50:44 PM
#23   Lannett Drops After FDA Approval With More Decisions Pending invest2win 07/02/11 08:32:16 AM
#22   LCI $4.80-$5.89 range with approval: Lannett receives mlkrborn 06/24/11 11:34:21 AM
#21   Too bad this one is not reacting to DADDY FAT SAXX 06/24/11 11:08:13 AM
#20   APPROVAL!!! DADDY FAT SAXX 06/24/11 10:28:12 AM
#19   Great news. I like it that they are Pennydog 06/24/11 09:45:44 AM